Testing effectiveness (Phase 2)Ended earlyNCT05245071
What this trial is testing
Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA
Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Sanofi 22